Citations

Showing 10 of 108119 citations.

Postoperative Opioid Prescribing After Female Pelvic Medicine and Reconstructive Surgery
Reagan, Krista, Boyles, Sarah Hamilton, Brueseke, Taylor, Linder, Brian J. , Willis‐Gray, Marcella G. , Cichowski, Sara , Linder, Brian J , Long, Jaime B.

Mayo Clinic

Female Pelvic Medicine & Reconstructive Surgery | October 20, 2021 | Volume: 27 | Issue: 11 | Pages: 643-653

10.1097/spv.0000000000001113 | PMID 34669653 Get It

Objective This study aimed to provide female pelvic medicine and reconstructive surgery (FPMRS) providers with evidence-based guidance on opioid prescribing following surgery. Methods A literature search of English language publications between January 1, 2000, and March 31, 2021, was conducted. Search terms identified reports on opioid prescribing, perioperative opioid use, and postoperative pain after FPMRS procedures. Publications were screened, those meeting inclusion criteria were reviewed, and data were abstracted. Data regarding the primary objective included the oral morphine milligram equivalents of opioid prescribed and used after discharge. Information meeting criteria for the secondary objectives was collected, and qualitative data synthesis was performed to generate evidence-based practice guidelines for prescription of opioids after FPMRS procedures. Results A total of 6,028 unique abstracts were identified, 452 were screened, and 198 full-text articles were assessed for eligibility. Fifteen articles informed the primary outcome, and 32 informed secondary outcomes. Conclusions For opioid-naive patients undergoing pelvic reconstructive surgery, we strongly recommend surgeons to provide no more than 15 tablets of opioids (roughly 112.5 morphine milligram equivalents) on hospital discharge. In cases where patients use no or little opioids in the hospital, patients may be safely discharged without postoperative opioids. Second, patient and surgical factors that may have an impact on opioid use should be assessed before surgery. Third, enhanced recovery pathways should be used to improve perioperative care, optimize pain control, and minimize opioid use. Fourth, systemic issues that lead to opioid overprescribing should be addressed. Female pelvic medicine and reconstructive surgery surgeons must aim to balance adequate postoperative pain control with individual and societal risks associated with excess opioid prescribing.
Classifying Esophageal Motility by FLIP Panometry: A Study of 722 Subjects With Manometry
Carlson, Dustin A. , Gyawali, C. Prakash , Khan, Abraham, Chen, Joan W. , Chokshi, Reena V. , Clarke, John O. , Garza, Jose M. , Jain, Anand , Katz, Philip O. , Konda, Vani J. , Lynch, Kristle L. , Schnoll‐Sussman, Felice , Vela, Marcelo F. , Prescott, Jacqueline, Baumann, Alexandra J. , Donnan, Erica N. , Pandolfino, John E. , Clarke, J , Gyawali, C P , Khan, Abraham, Yadlapati, Rena , Spechler, Stuart Jon , Kou, Wenjun , Kahrilas, Peter J.

Mayo Clinic

American Journal of Gastroenterology | October 20, 2021 | Volume: 116 | Issue: 12 | Pages: 2357-2366

10.14309/ajg.0000000000001532 | PMID 34668487 Get It

INTRODUCTION: Functional luminal imaging probe (FLIP) panometry can evaluate esophageal motility in response to sustained esophageal distension at the time of sedated endoscopy. This study aimed to describe a classification of esophageal motility using FLIP panometry and evaluate it against high-resolution manometry (HRM) and Chicago Classification v4.0 (CCv4.0). METHODS: Five hundred thirty-nine adult patients who completed FLIP and HRM with a conclusive CCv4.0 diagnosis were included in the primary analysis. Thirty-five asymptomatic volunteers (“controls”) and 148 patients with an inconclusive CCv4.0 diagnosis or systemic sclerosis were also described. Esophagogastric junction (EGJ) opening and the contractile response (CR) to distension (i.e., secondary peristalsis) were evaluated with a 16-cm FLIP during sedated endoscopy and analyzed using a customized software program. HRM was classified according to CCv4.0. RESULTS: In the primary analysis, 156 patients (29%) had normal motility on FLIP panometry, defined by normal EGJ opening and a normal or borderline CR; 95% of these patients had normal motility or ineffective esophageal motility on HRM. Two hundred two patients (37%) had obstruction with weak CR, defined as reduced EGJ opening and absent CR or impaired/disordered CR, on FLIP panometry; 92% of these patients had a disorder of EGJ outflow per CCv4.0. DISCUSSION: Classifying esophageal motility in response to sustained distension with FLIP panometry parallels the swallow-associated motility evaluation provided with HRM and CCv4.0. Thus, FLIP panometry serves as a well-tolerated method that can complement, or in some cases be an alternative to HRM, for evaluating esophageal motility disorders.
Can We Eliminate Opioids After Anterior Cruciate Ligament Reconstruction? A Prospective, Randomized Controlled Trial
Moutzouros, Vasilios , Jildeh, Toufic R. , Meta, Fabien , Okoroha, Kelechi R. , Okoroha, Kelechi R , Tramer, Joseph S. , Kuhlmann, N , Cross, Austin G.

Mayo Clinic

The American Journal of Sports Medicine | October 20, 2021 | Volume: 49 | Issue: 14 | Pages: 3794-3801

10.1177/03635465211045394 | PMID 34668795 Get It

Background: Multimodal pain protocols have been effective for postsurgical pain control; however, no published protocol has been effective in eliminating opioid consumption. Purpose: To compare a multimodal nonopioid pain protocol versus traditional opioid medication for postoperative pain control in patients undergoing anterior cruciate ligament reconstruction (ACLR). Study Design: Randomized controlled trial; Level of evidence, 1. Methods: A total of 90 patients undergoing primary ACLR were assessed for participation. We performed a prospective, randomized controlled trial in accordance with the CONSORT (Consolidated Standards of Reporting Trials) 2010 statement. The study arms were a multimodal nonopioid analgesic protocol (acetaminophen, ketorolac, diazepam, gabapentin, and meloxicam) and a standard opioid regimen (hydrocodone-acetaminophen), and the primary outcome was postoperative visual analog scale (VAS) pain scores for 10 days. Secondary outcomes included patient-reported outcomes, complications, and satisfaction. The observers were blinded, and the patients were not blinded to the intervention. Results: A total of 9 patients did not meet inclusion criteria, and 19 patients declined participation. Thus, 62 patients were analyzed, with 28 patients randomized to the opioid group and 34 to the multimodal nonopioid group. Patients receiving the multimodal nonopioid pain regimen demonstrated significantly lower VAS scores compared with patients who received opioid pain medication ( P < .05). Patients were administered the Patient-Reported Outcomes Measurement and Information System Pain Interference Short Form, and no significant difference was found in patients’ preoperative scores (opioid group, 58.6 ± 7.9; multimodal nonopioid group, 57.5 ± 7.4; P = .385) and 1-week postoperative scores (opioid group, 66.3 ± 8.2; multimodal nonopioid group, 61.4 ± 8.8; P = .147). When we adjusted for possible confounders (age, sex, body mass index, graft type), no significant differences in pain control were found between the 2 groups. The most common adverse effects for both groups were drowsiness and constipation, with no difference between the groups. All patients in the multimodal nonopioid group reported satisfactory pain management. Conclusions: A multimodal nonopioid pain protocol provided at least equivalent pain control compared with traditional opioid analgesics in patients undergoing ACLR. Minimal side effects, which did not differ between groups, were noted, and all patients reported satisfaction with their pain management.
Patient Recommendations for Shared Decision-Making in Uterine Fibroid Treatment Decisions
Riggan, Kirsten A. , Venable, Sateria, Allyse, Megan , Balls-Berry, Joyce E, Allyse, Megan A , Riggan, Kirsten A , Stewart, Elizabeth A. , Balls‐Berry, Joyce E.

Mayo Clinic

Journal of Patient Experience | October 20, 2021 | Volume: 8 | Issue: No issue available | Pages: No page available

10.1177/23743735211049655 | PMID 34692992 Get It

Uterine fibroids are noncancerous tumors associated with significant morbidity among symptomatic patients. While medical and surgical treatments have expanded, hysterectomy remains common. We interviewed women diagnosed with uterine fibroids ( n = 47) to explore their experiences and recommendations for shared decision-making. A majority were non-Hispanic Black, highly educated (51.1%), and had graduate degrees (40.4%). Participants with both positive and negative provider experiences expressed a desire for a more proactive therapeutic approach, including a presentation by their provider of the spectrum of medical and surgical treatment options, and greater provider recognition of the impact of symptoms on quality of life. Women advocated for expanded shared decision-making that acknowledged their contribution to their own treatment plan and felt early screening and improved patient/provider education of uterine fibroid symptoms would facilitate greater congruence between treatment approaches and patient goals. Perceptions of insufficient input into their treatment plans frequently served as a barrier to care-seeking and treatment acceptance among women with uterine fibroid symptoms. Improved discussion of treatment options in the context of the unique symptom burden and values of the patient may facilitate greater provider trust and acceptance of uterine fibroid treatment.
The Need for Allyship in Achieving Gender Equity in Gastroenterology
Oxentenko, Amy S. , Oxentenko, Amy S , Bilal, Mohammad , Balzora, Sophie , Pochapin, Mark

Mayo Clinic

American Journal of Gastroenterology | October 20, 2021 | Volume: 116 | Issue: 12 | Pages: 2321-2323

10.14309/ajg.0000000000001508 | PMID 34665160 Get It

A Multidimensional Cross-Sectional Analysis of Coronavirus Disease 2019 Seroprevalence Among a Police Officer Cohort: The PoliCOV-19 Study
Sendi, Parham , Thierstein, Marc, Widmer, Nadja , Gowland, Peter , Gahl, Brigitta , Büchi, Annina Elisabeth , Güntensperger, Dominik , Wider, Manon , Blum, Manuel R. , Tinguely, Caroline , Maillat, Cédric, Theel, Elitza S. , Berbari, Elie F. , Dijkman, Ronald , Niederhauser, Christoph , Baldan, Rossella , Gowland, Peter , Gahl, Brigitta , Büchi, Annina Elisabeth , Güntensperger, Dominik , Wider, Manon , Blum, Manuel Raphael , Tinguely, Caroline , Theel, Elitza S , Berbari, Elie F , Dijkman, Ronald , Niederhauser, Christoph , Sendi, Parham

Mayo Clinic

Open Forum Infectious Diseases | October 20, 2021 | Volume: 8 | Issue: 12 | Pages: No page available

10.1093/ofid/ofab524 | PMID 34888394 Get It

Abstract Background Protests and police fieldwork provide a high-exposure environment for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infections. In this cross-sectional analysis, we investigated the seroprevalence among a police cohort, and sociodemographic, work, and health-related factors associated with seropositivity. Methods Study participants were invited for serological testing of SARS-CoV-2 and to complete online questionnaires. Serum neutralization titers toward the wild-type SARS-CoV-2 spike protein (expressing D614G) and the Alpha and Beta variants were measured in seropositive study participants. Results A total of 978 police personnel representing 35% of the entire staff participated from February to March 2021. The seroprevalence was 12.9%. It varied by geographic region, ranged from 9% to 13.5% in 3 regions, including the city; and was 22% in Bernese Seeland/Jura with higher odds for seropositivity (odds ratio [OR], 2.38 [95% confidence interval {CI}, 1.28–4.44], P=.006). Job roles with mainly office activity were associated with a lower risk of seropositivity (OR, 0.33 [95% CI, .14–.77], P=.010). Self-reported compliance with mask wearing during working hours was 100%; 45% of seropositive vs 5% of seronegative participants (P&lt;.001) reported having had contact with a proven coronavirus disease 2019 (COVID-19) case living in the same household prior to serological testing. The level of serum antibody titers correlated with neutralization capacity. Antibodies derived from natural SARS-CoV-2 infection effectively neutralized the SARS-CoV-2 spike protein, but were less effective against the Alpha and Beta variants. Conclusions The seroprevalence of anti–SARS-CoV-2 antibodies of police officers was comparable to that reported in the general population, suggesting that the personal protective equipment of the police is effective, and that household contacts are the leading transmission venues. The level of serum antibody titers, in particular that of anti-spike antibodies, correlated well with neutralization capacity. Low antibody titers acquired from natural infection were not effective against variants. Clinical Trials Registration NCT04643444.
A Review of Commercially Available Cellular-based Allografts
Pinter, Zachariah W., Elder, Benjamin D., Kaye, I. David, Kepler, Christopher K., Wagner, Scott, Freedman, Brett A., Sebastian, Arjun S., Kepler, Christopher K. , Pinter, Zachariah W., Elder, Benjamin D., Kaye, I. David, Wagner, Scott, Freedman, Brett A., Sebastian, Arjun S.

Mayo Clinic

Clinical Spine Surgery | October 20, 2021 | Volume: 35 | Issue: 1 | Pages: E77-E86

10.1097/bsd.0000000000001262 | PMID 34654775 Get It

Study Design: This was a narrative review. Objective: This review discusses our current knowledge regarding cellular-based allografts while highlighting the key gaps in the literature that must be addressed before their widespread adoption. Summary of Background Data: Iliac crest bone graft is the gold-standard bone graft material but is associated with donor site morbidity. Commonly utilized bone graft extenders such as demineralized bone matrix and bone morphogenetic protein have conflicting data supporting their efficacy and lack the osteogenic potential of new cellular-based allograft options. Methods: An extensive literature review was performed. The literature was then summarized in accordance with the authors’ clinical experience. Results: There is not widespread evidence thus far that the addition of the osteogenic cellular component to allograft enhances spinal fusion, as a recent study by Bhamb and colleagues demonstrated superior bone formation during spine fusion in an aythmic rat model when demineralized bone matrix was used in comparison to Osteocel Plus. Furthermore, the postimplantation cellular viability and osteogenic and osteoinductive capacity of cellular-based allografts need to be definitively established, especially given that a recent study by Lina and colleagues demonstrated a paucity of bone marrow cell survival in an immunocompetent mouse posterolateral spinal fusion model. Conclusions: This data indicates that the substantially increased cost of these cellular allografts may not be justified. Level of Evidence: Level V.
Predicting Anterior Cruciate Ligament Reconstruction Revision
Martin, R. Kyle , Wastvedt, Solvejg , Pareek, Ayoosh , Visnes, Håvard , Fenstad, Anne Marie , Moatshe, Gilbert , Wolfson, Julian , Engebretsen, Lars , Persson, Andreas , Visnes, Håvard , Fenstad, Anne Marie , Moatshe, Gilbert , Wolfson, Julian , Engebretsen, Lars , Persson, Anders

Mayo Clinic

Journal of Bone and Joint Surgery | October 20, 2021 | Volume: 104 | Issue: 2 | Pages: 145-153

10.2106/jbjs.21.00113 | PMID 34662318 Get It

Background: Several factors are associated with an increased risk of anterior cruciate ligament (ACL) reconstruction revision. However, the ability to accurately translate these factors into a quantifiable risk of revision at a patient-specific level has remained elusive. We sought to determine if machine learning analysis of the Norwegian Knee Ligament Register (NKLR) can identify the most important risk factors associated with subsequent revision of primary ACL reconstruction and develop a clinically meaningful calculator for predicting revision of primary ACL reconstruction. Methods: Machine learning analysis was performed on the NKLR data set. The primary outcome was the probability of revision ACL reconstruction within 1, 2, and/or 5 years. Data were split randomly into training sets (75%) and test sets (25%). Four machine learning models were tested: Cox Lasso, survival random forest, generalized additive model, and gradient boosted regression. Concordance and calibration were calculated for all 4 models. Results: The data set included 24,935 patients, and 4.9% underwent a revision surgical procedure during a mean follow-up (and standard deviation) of 8.1 ± 4.1 years. All 4 models were well-calibrated, with moderate concordance (0.67 to 0.69). The Cox Lasso model required only 5 variables for outcome prediction. The other models either used more variables without an appreciable improvement in accuracy or had slightly lower accuracy overall. An in-clinic calculator was developed that can estimate the risk of ACL revision (Revision Risk Calculator). This calculator can quantify risk at a patient-specific level, with a plausible range from near 0% for low-risk patients to 20% for high-risk patients at 5 years. Conclusions: Machine learning analysis of a national knee ligament registry can predict the risk of ACL reconstruction revision with moderate accuracy. This algorithm supports the creation of an in-clinic calculator for point-of-care risk stratification based on the input of only 5 variables. Similar analysis using a larger or more comprehensive data set may improve the accuracy of risk prediction, and future studies incorporating patients who have experienced failure of ACL reconstruction but have not undergone subsequent revision may better predict the true risk of ACL reconstruction failure. Level of Evidence: Prognostic Level III . See Instructions for Authors for a complete description of levels of evidence.
Performing Lumbosacral Transdiscal Fixation
Sebastian, Arjun S. , Monsef, Jad Bou , Elder, Benjamin D. , Fogelson, Jeremy L. , Elder, Benjamin, Fogelson, Jeremy, Pinter, Zachariah W.

Mayo Clinic

Clinical Spine Surgery | October 20, 2021 | Volume: 35 | Issue: 5 | Pages: 208-212

10.1097/bsd.0000000000001257 | PMID 34654774 Get It

Transdiscal screw fixation through the Boachie screw technique at the lumbosacral junction is a well-accepted procedure in the treatment of high-grade spondylolisthesis. This technique allows for partial reduction of the spondylolisthesis, decompression of the neural elements, and reliable posterior lumbosacral fixation. When performed properly, this procedure produces reliable results and high rates of arthrodesis with relief of preoperative neurological symptoms.
Burn Center Patients at Risk for Upper Extremity Amputations
Thornburg, Danielle A. , Spadafore, Philomene, Kowal-Vern, Areta , Foster, Kevin N , Matthews, Marc R. , Swanson, Steven

Mayo Clinic

Plastic Surgery | October 20, 2021 | Volume: 31 | Issue: 3 | Pages: 229-235

10.1177/22925503211042863 | PMID 37654535 Get It

Introduction Burn center patients present not only with burn injuries but also necrotizing infections, purpura fulminans, frostbite, toxic epidermal necrolysis, chronic wounds, and trauma. Burn surgeons are often faced with the need to amputate when limb salvage is no longer a viable option. The purpose of this study was to determine factors which predispose patients to extremity amputations. Methods: This retrospective registry review (2000-2019) compared patients who required upper extremity amputations with those who did not. Cases were pair-matched by age, sex, percent total body surface area (%TBSA), and type/location of injury to control for possible confounding variables. Results: There were 77 upper extremity amputee patients (APs) and 77 pair-matched non-amputees (NAPs) with the median age 45- and 43-years, %TBSA 21 and 10, respectively; second and third degree burn injuries were similar in the 2 groups. The AP group had longer hospitalizations (median 40 vs 15 days) P < .0001, with more intensive care unit days (median 28 vs 18 days). APs presented with significantly more cardiac, renal, and pulmonary comorbidities, acquired infections (61 [64%] vs 35 [36%]), escharotomies, and fasciotomies than the NAP, P < .0001. Mortality was similar (AP 14 [18.2%] vs NAP 9 [11.7%]), P = .26. Conclusions: Escharotomies, fasciotomies, sepsis, pneumonia, wound, and urinary tract infections contributed to prolonged hospitalizations and increased risk for upper extremity amputations in the AP group.